60
Views
9
CrossRef citations to date
0
Altmetric
Review

Economic evaluations of human papillomavirus vaccines

&
Pages 251-267 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Allex Jardim Fonseca & Luiz Carlos de Lima Ferreira. (2014) Systematic review of the cost-effectiveness of the vaccination against HPV in Brazil. Human Vaccines & Immunotherapeutics 10:12, pages 3484-3490.
Read now
Erik J Dasbach, Nathalie Largeron & Elamin H Elbasha. (2008) Assessment of the cost–effectiveness of a quadrivalent HPV vaccine in Norway using a dynamic transmission model. Expert Review of Pharmacoeconomics & Outcomes Research 8:5, pages 491-500.
Read now
Ralph P Insinga, Erik J Dasbach & Elamin H Elbasha. (2008) Structural differences among cost–effectiveness models of human papillomavirus vaccines. Expert Review of Vaccines 7:7, pages 895-913.
Read now

Articles from other publishers (6)

Danuta Bryzek, Izabela Ciaston, Ewelina Dobosz, Anna Gasiorek, Anna Makarska, Michal Sarna, Sigrun Eick, Magdalena Puklo, Maciej Lech, Barbara Potempa, Jan Potempa & Joanna Koziel. (2019) Triggering NETosis via protease-activated receptor (PAR)-2 signaling as a mechanism of hijacking neutrophils function for pathogen benefits. PLOS Pathogens 15:5, pages e1007773.
Crossref
Mélanie Drolet, Élodie Bénard, Mark Jit, Raymond Hutubessy & Marc Brisson. (2018) Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature. Value in Health 21:10, pages 1250-1258.
Crossref
Bernhard Ultsch, Oliver Damm, Philippe Beutels, Joke Bilcke, Bernd Brüggenjürgen, Andreas Gerber-Grote, Wolfgang Greiner, Germaine Hanquet, Raymond Hutubessy, Mark Jit, Mirjam Knol, Rüdiger von Kries, Alexander Kuhlmann, Daniel Levy-Bruhl, Matthias Perleth, Maarten Postma, Heini Salo, Uwe Siebert, Jürgen Wasem & Ole Wichmann. (2015) Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics 34:3, pages 227-244.
Crossref
Suzanne M. Garland, Ralph P. Insinga, Heather L. Sings, Richard M. Haupt & Elmar A. Joura. (2009) Human Papillomavirus Infections and Vulvar Disease Development. Cancer Epidemiology, Biomarkers & Prevention 18:6, pages 1777-1784.
Crossref
Jaume Puig-Junoy & Beatriz G. Lopez-Valcarcel. (2009) Economic evaluations of massive HPV vaccination: Within-study and between study variations in incremental cost per QALY gained. Preventive Medicine 48:5, pages 444-448.
Crossref
Maurizio Bonati & Silvio Garattini. (2009) Controlling Cervical Cancer. PharmacoEconomics 27:2, pages 91-93.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.